ҹɫè

ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý CV

Name

Massimo Pancione

Gender

Male

Ìý

Birth date

October, 1, 1974

Nationality

Italy

H/index

ÌýI have published more than 42 papers over my career. total SCI citation 1053, H-index 20, calculated by .

Ìý

Institute

University of Sannio, Benevento,, Italy

ҹɫè

ҹɫè of Sciences and Technology (DST)

Title

PhD

Ìý

Mobile

+393511161887

e-mail

massimo.pancione@unisannio.it

Ìý

Corresponding address

Laboratory of Molecular Oncology and Signal Transduction, DST, Via Francesco De Sanctis, 82100 Benevento, Italy

Ìý

Education

• From 1995 to 2000: BSc in Biochemistry at the (University of Naples, Federico II, Italy)
• From 2000 to 2001: Post-graduate training in mice model of intestinal diseases,Ìý National Research Council, Avellino, ItalyÌýÌý
• From 2002 to 2003: Fellowship at the Spanish National Cancer Research Center, Madrid, Spain.ÌýÌý
• From 2004 to 2008: PhD in Molecular Biology Ìýat ҹɫè of Biological and Environmental Sciences, University of Sannio,ÌýÌý Benevento, Italy
• From 2009 to present: permanent Researcher and associate professorÌý of Molecular ÌýBiology
• From 2015 to present: researcher staff at ҹɫè of Biochemistry and Molecular Biology, Faculty of Farmacy, Complutense University, Madrid, SpainÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

Ìý

Ìý

Ìý

Research Work experience

Massimo PancioneÌý received his B.A. degree in biochemistry from University of Naples, Federico II, Italy and its PhD degree fromÌý University of Sannio, Benevento, Italy. He worked on the human promoter of the retinol binding protein Ìýas undergraduate student with Prof. Vittorio ColantuoniÌý in Naples. Next, he completed a researchÌý training at National Research Council, Avellino, Italy andÌý the Spanish National Cancer Research Center, Madrid, Spain working on a mice models of intestinal diseaseÌý and cancer.ÌýÌý ÌýWhile working in Dr. Colantuoni laboratory he was the first to discover a link betweenÌý epigenetic modulation of PPARG and human colorectal cancers, a finding considered as a milestone in the field.Ìý He is currentlyÌý a Researcher of Molecular BiologyÌý and heads the laboratory of MolecularÌý Oncology and signal Transduction at ҹɫè of Science and Technology, University of Sannio, Benevento, Italy. In the last years, his research has focused on understanding the molecular basis of how malignant cells evade immune system mediate-destruction with applicability for predictive prognostic markers and implementation of molecularly targeted cancer therapies. The translational impact of novel therapeutic targets as well as molecules for the treatment of colorectal is one of the main aims of the laboratory. Another major interest is the study of theÌý centrosome linker proteins in health and diseases. These latter studies are beginning to shed light on the molecular basis of mitotic errors in extremely malignant human disorders.

Ìý

Ìý

ACADEMIC AWARDS FOR SCIENTIFIC RESEARCH ACHIEVEMENTS

Dr. Pancione serves on the Scientific Advisory Committees of academic and private sector research organizations and is a member of several editorial boards including: Scientific Report (Nature Group), Gastroenterology research and practice (Hindawi Group).Ìý Bentham Ambassador for (Bentham Science group), Cancer Research UK, euroscicon controlling cancer summit; Italian society of Cancerology, Czech health research council. He has received awards by both public and private sector research organizations.

Ìý

Ìý